Satralizumab-mwge Injection

Generic name: Pronounced as (sat" ra liz' ue mab)
Brand names
  • Enspryng®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 12/15/2020

Satralizumab-mwge injection is used to treat neuromyelitis optica spectrum disorder (NMOSD; an autoimmune disorder of the nervous system that affects eye nerves and the spinal cord) in certain adults. Satralizumab-mwge is in a class of medications called interleukin-6 (IL-6) receptor inhibitors. It works by blocking the activity of the part of the immune system that may damage certain areas of the nervous system in people with NMOSD.

Satralizumab-mwge comes as a solution (liquid) to inject subcutaneously (under the skin). It is usually injected once every 2 weeks for the first 3 doses and then once every 4 weeks as long as your doctor recommends that you receive treatment. Your doctor may decide that you or your caregiver can perform the injections at home. Your doctor will show you or the person who will be injecting the medication how to inject it. You or the person who will be injecting the medication should also read the written instructions for use that come with the medication. Be sure to ask your doctor or pharmacist if you have any questions about how to inject the medication.

Remove the carton containing the medication from the refrigerator 30 minutes before your are ready to inject the medication. Check the carton to be sure that the expiration date printed on the package has not passed. Open the carton and remove the syringe. Look closely at the liquid in the syringe. The liquid should be clear and colorless to slightly yellow and should not be cloudy or discolored or contain particles. Call your pharmacist if there are any problems and do not inject the medication. Place the syringe on a flat surface and allow it to reach room temperature. Do not shake the syringe. Do not try to warm the medication by heating it in a microwave, placing it in warm water or in direct sunlight, or through any other method.

You may inject satralizumab-mwge injection on the front and middle of the thighs or anywhere on your stomach except your navel (belly button) and the area 2 inches around it. Do not inject the medication into skin that is tender, bruised, damaged, or scarred. Change (rotate) the injection site with each injection. Choose a different spot each time you inject the medication. Use the syringe within 5 minutes of removing the cap or the needle may clog.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with satralizumab-mwge injection and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before using satralizumab-mwge injection,

  • tell your doctor and pharmacist if you are allergic to satralizumab-mwge, any other medications, or any of the ingredients in satralizumab-mwge injection. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had tuberculosis (TB; a serious lung infection) or hepatitis B (HBV; a virus that affects the liver). Your doctor will test you to see if you have TB or HBV before you begin your treatment. If you have TB or HBV, your doctor will probably tell you not to use satralizumab-mwge injection.

  • tell your doctor if you have an infection or have had or have been in contact with someone with tuberculosis. Also, tell your doctor if you have liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while using satralizumab-mwge, call your doctor.

  • ask your doctor whether you should receive any vaccinations before you begin your treatment with satralizumab-mwge injection. Do not have any vaccinations before or during your treatment without talking to your doctor.

Unless your doctor tells you otherwise, continue your normal diet.

If you miss a dose of satralizumab-mwge, call your doctor about restarting your treatment schedule.

  • Satralizumab-mwge may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • joint or muscle pain

    • pain in hands or feet

    • depression

    • headache

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

    • fever, cough, diarrhea, runny nose, sore throat, chills, aches, burning when you urinate, urinating more often than usual or other signs of infection

    • skin redness, swelling, tenderness, pain or sores

    • rash or hives

    • swelling of the face, lips, or tongue

    • difficulty swallowing or breathing

  • Satralizumab-mwge may cause other side effects. Call your doctor if you have any unusual problems while using this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, out of reach of children, and away from light. Store prefilled syringes in the refrigerator; do not freeze. Unopened cartons containing the syringes can be removed and returned to the refrigerator, but should not be out of the refrigerator for a total time of greater than 8 days.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests before and during your treatment to check your body's response to satralizumab-mwge.

Do not let anyone else use your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Candesartan Candesartan The serum concentration of Candesartan can be decreased when it is combined with Satralizumab.
Cilostazol Cilostazol The serum concentration of Cilostazol can be decreased when it is combined with Satralizumab.
Triamcinolone Triamcinolone The serum concentration of Triamcinolone can be decreased when it is combined with Satralizumab.
Zolmitriptan Zolmitriptan The serum concentration of Zolmitriptan can be decreased when it is combined with Satralizumab.
Zidovudine Injection Zidovudine Injection The serum concentration of Zidovudine can be decreased when it is combined with Satralizumab.
Trimipramine Trimipramine The serum concentration of Trimipramine can be decreased when it is combined with Satralizumab.
Tenofovir Tenofovir The serum concentration of Tenofovir can be decreased when it is combined with Satralizumab.
Eletriptan Eletriptan The serum concentration of Eletriptan can be decreased when it is combined with Satralizumab.
Alfuzosin Alfuzosin The serum concentration of Alfuzosin can be decreased when it is combined with Satralizumab.
Frovatriptan Frovatriptan The serum concentration of Frovatriptan can be decreased when it is combined with Satralizumab.
Tinidazole Tinidazole The serum concentration of Tinidazole can be decreased when it is combined with Satralizumab.
Voriconazole Voriconazole The serum concentration of Voriconazole can be decreased when it is combined with Satralizumab.
Darifenacin Darifenacin The serum concentration of Darifenacin can be decreased when it is combined with Satralizumab.
Tipranavir Tipranavir The serum concentration of Tipranavir can be decreased when it is combined with Satralizumab.
Rasagiline Rasagiline The serum concentration of Rasagiline can be decreased when it is combined with Satralizumab.
Dronabinol Dronabinol The serum concentration of Dronabinol can be decreased when it is combined with Satralizumab.
Bexarotene Bexarotene The serum concentration of Bexarotene can be decreased when it is combined with Satralizumab.
Budesonide Budesonide The serum concentration of Budesonide can be decreased when it is combined with Satralizumab.
Tretinoin Tretinoin The serum concentration of Tretinoin can be decreased when it is combined with Satralizumab.
Bendamustine Injection Bendamustine Injection The serum concentration of Bendamustine can be decreased when it is combined with Satralizumab.
Betaxolol Betaxolol The serum concentration of Betaxolol can be decreased when it is combined with Satralizumab.
Everolimus Everolimus The serum concentration of Everolimus can be decreased when it is combined with Satralizumab.
Dronedarone Dronedarone The serum concentration of Dronedarone can be decreased when it is combined with Satralizumab.
Ulipristal Ulipristal The serum concentration of Ulipristal can be decreased when it is combined with Satralizumab.
Lurasidone Lurasidone The serum concentration of Lurasidone can be decreased when it is combined with Satralizumab.
Acetaminophen Injection Acetaminophen Injection The serum concentration of Acetaminophen can be decreased when it is combined with Satralizumab.
Vilazodone Vilazodone The serum concentration of Vilazodone can be decreased when it is combined with Satralizumab.
Busulfan Injection Busulfan Injection The serum concentration of Busulfan can be decreased when it is combined with Satralizumab.
Roflumilast Roflumilast The serum concentration of Roflumilast can be decreased when it is combined with Satralizumab.
Linagliptin Linagliptin The serum concentration of Linagliptin can be decreased when it is combined with Satralizumab.
Rilpivirine Rilpivirine The serum concentration of Rilpivirine can be decreased when it is combined with Satralizumab.
Abiraterone Abiraterone The serum concentration of Abiraterone can be decreased when it is combined with Satralizumab.
Rivaroxaban Rivaroxaban The serum concentration of Rivaroxaban can be decreased when it is combined with Satralizumab.
Ticagrelor Ticagrelor The serum concentration of Ticagrelor can be decreased when it is combined with Satralizumab.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The serum concentration of Brentuximab vedotin can be decreased when it is combined with Satralizumab.
Ruxolitinib Ruxolitinib The serum concentration of Ruxolitinib can be decreased when it is combined with Satralizumab.
Vandetanib Vandetanib The serum concentration of Vandetanib can be decreased when it is combined with Satralizumab.
Clobazam Clobazam The serum concentration of Clobazam can be decreased when it is combined with Satralizumab.
Vemurafenib Vemurafenib The serum concentration of Vemurafenib can be decreased when it is combined with Satralizumab.
Vismodegib Vismodegib The serum concentration of Vismodegib can be decreased when it is combined with Satralizumab.
Ivacaftor Ivacaftor The serum concentration of Ivacaftor can be decreased when it is combined with Satralizumab.
Axitinib Axitinib The serum concentration of Axitinib can be decreased when it is combined with Satralizumab.
Crizotinib Crizotinib The serum concentration of Crizotinib can be decreased when it is combined with Satralizumab.
Enzalutamide Enzalutamide The serum concentration of Enzalutamide can be decreased when it is combined with Satralizumab.
Mirabegron Mirabegron The serum concentration of Mirabegron can be decreased when it is combined with Satralizumab.
Regorafenib Regorafenib The serum concentration of Regorafenib can be decreased when it is combined with Satralizumab.
Bosutinib Bosutinib The serum concentration of Bosutinib can be decreased when it is combined with Satralizumab.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The serum concentration of Cabozantinib can be decreased when it is combined with Satralizumab.
Bedaquiline Bedaquiline The serum concentration of Bedaquiline can be decreased when it is combined with Satralizumab.
Tofacitinib Tofacitinib The serum concentration of Tofacitinib can be decreased when it is combined with Satralizumab.
Alogliptin Alogliptin The serum concentration of Alogliptin can be decreased when it is combined with Satralizumab.
Ponatinib Ponatinib The serum concentration of Ponatinib can be decreased when it is combined with Satralizumab.
Pomalidomide Pomalidomide The serum concentration of Pomalidomide can be decreased when it is combined with Satralizumab.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The serum concentration of Trastuzumab emtansine can be decreased when it is combined with Satralizumab.
Apixaban Apixaban The serum concentration of Apixaban can be decreased when it is combined with Satralizumab.
Canagliflozin Canagliflozin The serum concentration of Canagliflozin can be decreased when it is combined with Satralizumab.
Dabrafenib Dabrafenib The serum concentration of Dabrafenib can be decreased when it is combined with Satralizumab.
Ospemifene Ospemifene The serum concentration of Ospemifene can be decreased when it is combined with Satralizumab.
Levomilnacipran Levomilnacipran The serum concentration of Levomilnacipran can be decreased when it is combined with Satralizumab.
Vortioxetine Vortioxetine The serum concentration of Vortioxetine can be decreased when it is combined with Satralizumab.
Perampanel Perampanel The serum concentration of Perampanel can be decreased when it is combined with Satralizumab.
Ibrutinib Ibrutinib The serum concentration of Ibrutinib can be decreased when it is combined with Satralizumab.
Lomitapide Lomitapide The serum concentration of Lomitapide can be decreased when it is combined with Satralizumab.
Avanafil Avanafil The serum concentration of Avanafil can be decreased when it is combined with Satralizumab.
Simeprevir Simeprevir The serum concentration of Simeprevir can be decreased when it is combined with Satralizumab.
Dapagliflozin Dapagliflozin The serum concentration of Dapagliflozin can be decreased when it is combined with Satralizumab.
Apremilast Apremilast The serum concentration of Apremilast can be decreased when it is combined with Satralizumab.
Ceritinib Ceritinib The serum concentration of Ceritinib can be decreased when it is combined with Satralizumab.
Idelalisib Idelalisib The serum concentration of Idelalisib can be decreased when it is combined with Satralizumab.
Testosterone Injection Testosterone Injection The serum concentration of Testosterone can be decreased when it is combined with Satralizumab.
Vorapaxar Vorapaxar The serum concentration of Vorapaxar can be decreased when it is combined with Satralizumab.
Suvorexant Suvorexant The serum concentration of Suvorexant can be decreased when it is combined with Satralizumab.
Olaparib Olaparib The serum concentration of Olaparib can be decreased when it is combined with Satralizumab.
Tasimelteon Tasimelteon The serum concentration of Tasimelteon can be decreased when it is combined with Satralizumab.
Riociguat Riociguat The serum concentration of Riociguat can be decreased when it is combined with Satralizumab.
Pirfenidone Pirfenidone The serum concentration of Pirfenidone can be decreased when it is combined with Satralizumab.
Nintedanib Nintedanib The serum concentration of Nintedanib can be decreased when it is combined with Satralizumab.
Palbociclib Palbociclib The serum concentration of Palbociclib can be decreased when it is combined with Satralizumab.
Lenvatinib Lenvatinib The serum concentration of Lenvatinib can be decreased when it is combined with Satralizumab.
Naloxegol Naloxegol The serum concentration of Naloxegol can be decreased when it is combined with Satralizumab.
Panobinostat Panobinostat The serum concentration of Panobinostat can be decreased when it is combined with Satralizumab.
Ivabradine Ivabradine The serum concentration of Ivabradine can be decreased when it is combined with Satralizumab.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Isavuconazonium can be decreased when it is combined with Satralizumab.
Macitentan Macitentan The serum concentration of Macitentan can be decreased when it is combined with Satralizumab.
Sonidegib Sonidegib The serum concentration of Sonidegib can be decreased when it is combined with Satralizumab.
Flibanserin Flibanserin The serum concentration of Flibanserin can be decreased when it is combined with Satralizumab.
Rolapitant Rolapitant The serum concentration of Rolapitant can be decreased when it is combined with Satralizumab.
Daclatasvir Daclatasvir The serum concentration of Daclatasvir can be decreased when it is combined with Satralizumab.
Brexpiprazole Brexpiprazole The serum concentration of Brexpiprazole can be decreased when it is combined with Satralizumab.
Ziprasidone Injection Ziprasidone Injection The serum concentration of Ziprasidone can be decreased when it is combined with Satralizumab.
Cariprazine Cariprazine The serum concentration of Cariprazine can be decreased when it is combined with Satralizumab.
Cobimetinib Cobimetinib The serum concentration of Cobimetinib can be decreased when it is combined with Satralizumab.
Trabectedin Injection Trabectedin Injection The serum concentration of Trabectedin can be decreased when it is combined with Satralizumab.
Osimertinib Osimertinib The serum concentration of Osimertinib can be decreased when it is combined with Satralizumab.
Ixazomib Ixazomib The serum concentration of Ixazomib can be decreased when it is combined with Satralizumab.
Lesinurad Lesinurad The serum concentration of Lesinurad can be decreased when it is combined with Satralizumab.
Brivaracetam Injection Brivaracetam Injection The serum concentration of Brivaracetam can be decreased when it is combined with Satralizumab.
Venetoclax Venetoclax The serum concentration of Venetoclax can be decreased when it is combined with Satralizumab.
Cobicistat Cobicistat The serum concentration of Cobicistat can be decreased when it is combined with Satralizumab.
Selexipag Selexipag The serum concentration of Selexipag can be decreased when it is combined with Satralizumab.
Rucaparib Rucaparib The serum concentration of Rucaparib can be decreased when it is combined with Satralizumab.
Ribociclib Ribociclib The serum concentration of Ribociclib can be decreased when it is combined with Satralizumab.
Brigatinib Brigatinib The serum concentration of Brigatinib can be decreased when it is combined with Satralizumab.
Deutetrabenazine Deutetrabenazine The serum concentration of Deutetrabenazine can be decreased when it is combined with Satralizumab.
Valbenazine Valbenazine The serum concentration of Valbenazine can be decreased when it is combined with Satralizumab.
Deflazacort Deflazacort The serum concentration of Deflazacort can be decreased when it is combined with Satralizumab.
Safinamide Safinamide The serum concentration of Safinamide can be decreased when it is combined with Satralizumab.
Midostaurin Midostaurin The serum concentration of Midostaurin can be decreased when it is combined with Satralizumab.
Neratinib Neratinib The serum concentration of Neratinib can be decreased when it is combined with Satralizumab.
Enasidenib Enasidenib The serum concentration of Enasidenib can be decreased when it is combined with Satralizumab.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The serum concentration of Fosaprepitant can be decreased when it is combined with Satralizumab.
Copanlisib Injection Copanlisib Injection The serum concentration of Copanlisib can be decreased when it is combined with Satralizumab.
Abemaciclib Abemaciclib The serum concentration of Abemaciclib can be decreased when it is combined with Satralizumab.
Acalabrutinib Acalabrutinib The serum concentration of Acalabrutinib can be decreased when it is combined with Satralizumab.
Buprenorphine Injection Buprenorphine Injection The serum concentration of Buprenorphine can be decreased when it is combined with Satralizumab.
Apalutamide Apalutamide The serum concentration of Apalutamide can be decreased when it is combined with Satralizumab.
Fostamatinib Fostamatinib The serum concentration of Fostamatinib can be decreased when it is combined with Satralizumab.
Baricitinib Baricitinib The serum concentration of Baricitinib can be decreased when it is combined with Satralizumab.
Eliglustat Eliglustat The serum concentration of Eliglustat can be decreased when it is combined with Satralizumab.
Encorafenib Encorafenib The serum concentration of Encorafenib can be decreased when it is combined with Satralizumab.
Binimetinib Binimetinib The serum concentration of Binimetinib can be decreased when it is combined with Satralizumab.
Ivosidenib Ivosidenib The serum concentration of Ivosidenib can be decreased when it is combined with Satralizumab.
Eravacycline Injection Eravacycline Injection The serum concentration of Eravacycline can be decreased when it is combined with Satralizumab.
Doravirine Doravirine The serum concentration of Doravirine can be decreased when it is combined with Satralizumab.
Cannabidiol Cannabidiol The serum concentration of Cannabidiol can be decreased when it is combined with Satralizumab.
Dacomitinib Dacomitinib The serum concentration of Dacomitinib can be decreased when it is combined with Satralizumab.
Duvelisib Duvelisib The serum concentration of Duvelisib can be decreased when it is combined with Satralizumab.
Stiripentol Stiripentol The serum concentration of Stiripentol can be decreased when it is combined with Satralizumab.
Gilteritinib Gilteritinib The serum concentration of Gilteritinib can be decreased when it is combined with Satralizumab.
Glasdegib Glasdegib The serum concentration of Glasdegib can be decreased when it is combined with Satralizumab.
Lorlatinib Lorlatinib The serum concentration of Lorlatinib can be decreased when it is combined with Satralizumab.
Larotrectinib Larotrectinib The serum concentration of Larotrectinib can be decreased when it is combined with Satralizumab.
Prucalopride Prucalopride The serum concentration of Prucalopride can be decreased when it is combined with Satralizumab.
Siponimod Siponimod The serum concentration of Siponimod can be decreased when it is combined with Satralizumab.
Erdafitinib Erdafitinib The serum concentration of Erdafitinib can be decreased when it is combined with Satralizumab.
Alpelisib Alpelisib The serum concentration of Alpelisib can be decreased when it is combined with Satralizumab.
Polatuzumab vedotin-piiq Injection Polatuzumab vedotin-piiq Injection The serum concentration of Polatuzumab vedotin can be decreased when it is combined with Satralizumab.
Selinexor Selinexor The serum concentration of Selinexor can be decreased when it is combined with Satralizumab.
Darolutamide Darolutamide The serum concentration of Darolutamide can be decreased when it is combined with Satralizumab.
Triclabendazole Triclabendazole The serum concentration of Triclabendazole can be decreased when it is combined with Satralizumab.
Entrectinib Entrectinib The serum concentration of Entrectinib can be decreased when it is combined with Satralizumab.
Upadacitinib Upadacitinib The serum concentration of Upadacitinib can be decreased when it is combined with Satralizumab.
Istradefylline Istradefylline The serum concentration of Istradefylline can be decreased when it is combined with Satralizumab.
Pitolisant Pitolisant The serum concentration of Pitolisant can be decreased when it is combined with Satralizumab.
Pretomanid Pretomanid The serum concentration of Pretomanid can be decreased when it is combined with Satralizumab.
Fedratinib Fedratinib The serum concentration of Fedratinib can be decreased when it is combined with Satralizumab.
Lefamulin Lefamulin The serum concentration of Lefamulin can be decreased when it is combined with Satralizumab.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be decreased when it is combined with Satralizumab.
Zanubrutinib Zanubrutinib The serum concentration of Zanubrutinib can be decreased when it is combined with Satralizumab.
Voxelotor Voxelotor The serum concentration of Voxelotor can be decreased when it is combined with Satralizumab.
Avapritinib Avapritinib The serum concentration of Avapritinib can be decreased when it is combined with Satralizumab.
Lumateperone Lumateperone The serum concentration of Lumateperone can be decreased when it is combined with Satralizumab.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be decreased when it is combined with Satralizumab.
Tazemetostat Tazemetostat The serum concentration of Tazemetostat can be decreased when it is combined with Satralizumab.
Cenobamate Cenobamate The serum concentration of Cenobamate can be decreased when it is combined with Satralizumab.
Pemigatinib Pemigatinib The serum concentration of Pemigatinib can be decreased when it is combined with Satralizumab.
Selumetinib Selumetinib The serum concentration of Selumetinib can be decreased when it is combined with Satralizumab.
Rimegepant Rimegepant The serum concentration of Rimegepant can be decreased when it is combined with Satralizumab.
Remdesivir Injection Remdesivir Injection The serum concentration of Remdesivir can be decreased when it is combined with Satralizumab.
Ripretinib Ripretinib The serum concentration of Ripretinib can be decreased when it is combined with Satralizumab.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be decreased when it is combined with Satralizumab.
Capmatinib Capmatinib The serum concentration of Capmatinib can be decreased when it is combined with Satralizumab.
Lemborexant Lemborexant The serum concentration of Lemborexant can be decreased when it is combined with Satralizumab.
Fostemsavir Fostemsavir The serum concentration of Fostemsavir can be decreased when it is combined with Satralizumab.
Lurbinectedin Injection Lurbinectedin Injection The serum concentration of Lurbinectedin can be decreased when it is combined with Satralizumab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The serum concentration of Drospirenone can be decreased when it is combined with Satralizumab.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The serum concentration of Vitamin E can be decreased when it is combined with Satralizumab.
Theophylline Theophylline The serum concentration of Theophylline can be decreased when it is combined with Satralizumab.
Trazodone Trazodone The serum concentration of Trazodone can be decreased when it is combined with Satralizumab.
Clorazepate Clorazepate The serum concentration of Clorazepic acid can be decreased when it is combined with Satralizumab.
Carmustine Carmustine The serum concentration of Carmustine can be decreased when it is combined with Satralizumab.
Bromocriptine Bromocriptine The serum concentration of Bromocriptine can be decreased when it is combined with Satralizumab.
Tetracycline Tetracycline The serum concentration of Tetracycline can be decreased when it is combined with Satralizumab.
Thioridazine Thioridazine The serum concentration of Thioridazine can be decreased when it is combined with Satralizumab.
Trifluoperazine Trifluoperazine The serum concentration of Trifluoperazine can be decreased when it is combined with Satralizumab.
Sulfadiazine Sulfadiazine The serum concentration of Sulfadiazine can be decreased when it is combined with Satralizumab.
Azathioprine Azathioprine The serum concentration of Azathioprine can be decreased when it is combined with Satralizumab.
Carbamazepine Carbamazepine The serum concentration of Carbamazepine can be decreased when it is combined with Satralizumab.
Warfarin Warfarin The serum concentration of Warfarin can be decreased when it is combined with Satralizumab.
Calcitriol Calcitriol The serum concentration of Calcitriol can be decreased when it is combined with Satralizumab.
Triamterene Triamterene The serum concentration of Triamterene can be decreased when it is combined with Satralizumab.
Sulfinpyrazone Sulfinpyrazone The serum concentration of Sulfinpyrazone can be decreased when it is combined with Satralizumab.
Valproic Acid Valproic Acid The serum concentration of Valproic acid can be decreased when it is combined with Satralizumab.
Tamoxifen Tamoxifen The serum concentration of Tamoxifen can be decreased when it is combined with Satralizumab.
Tolbutamide Tolbutamide The serum concentration of Tolbutamide can be decreased when it is combined with Satralizumab.
Tolazamide Tolazamide The serum concentration of Tolazamide can be decreased when it is combined with Satralizumab.
Cyclobenzaprine Cyclobenzaprine The serum concentration of Cyclobenzaprine can be decreased when it is combined with Satralizumab.
Carisoprodol Carisoprodol The serum concentration of Carisoprodol can be decreased when it is combined with Satralizumab.
Cephalexin Cephalexin The serum concentration of Cephalexin can be decreased when it is combined with Satralizumab.
Thiotepa Injection Thiotepa Injection The serum concentration of Thiotepa can be decreased when it is combined with Satralizumab.
Vincristine Injection Vincristine Injection The serum concentration of Vincristine can be decreased when it is combined with Satralizumab.
Vinblastine Vinblastine The serum concentration of Vinblastine can be decreased when it is combined with Satralizumab.
Thiothixene Thiothixene The serum concentration of Thiothixene can be decreased when it is combined with Satralizumab.
Aspirin Aspirin The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Satralizumab.
Triazolam Triazolam The serum concentration of Triazolam can be decreased when it is combined with Satralizumab.
Trimethoprim Trimethoprim The serum concentration of Trimethoprim can be decreased when it is combined with Satralizumab.
Timolol Timolol The serum concentration of Timolol can be decreased when it is combined with Satralizumab.
Verapamil Verapamil The serum concentration of Verapamil can be decreased when it is combined with Satralizumab.
Buspirone Buspirone The serum concentration of Buspirone can be decreased when it is combined with Satralizumab.
Clarithromycin Clarithromycin The serum concentration of Clarithromycin can be decreased when it is combined with Satralizumab.
Amlodipine Amlodipine The serum concentration of Amlodipine can be decreased when it is combined with Satralizumab.
Teniposide Injection Teniposide Injection The serum concentration of Teniposide can be decreased when it is combined with Satralizumab.
Bisoprolol Bisoprolol The serum concentration of Bisoprolol can be decreased when it is combined with Satralizumab.
Tramadol Tramadol The serum concentration of Tramadol can be decreased when it is combined with Satralizumab.
Lansoprazole Lansoprazole The serum concentration of Lansoprazole can be decreased when it is combined with Satralizumab.
Ticlopidine Ticlopidine The serum concentration of Ticlopidine can be decreased when it is combined with Satralizumab.
Indinavir Indinavir The serum concentration of Indinavir can be decreased when it is combined with Satralizumab.
Zafirlukast Zafirlukast The serum concentration of Zafirlukast can be decreased when it is combined with Satralizumab.
Mirtazapine Mirtazapine The serum concentration of Mirtazapine can be decreased when it is combined with Satralizumab.
Donepezil Donepezil The serum concentration of Donepezil can be decreased when it is combined with Satralizumab.
Nelfinavir Nelfinavir The serum concentration of Nelfinavir can be decreased when it is combined with Satralizumab.
Azithromycin Azithromycin The serum concentration of Azithromycin can be decreased when it is combined with Satralizumab.
Carvedilol Carvedilol The serum concentration of Carvedilol can be decreased when it is combined with Satralizumab.
Efavirenz Efavirenz The serum concentration of Efavirenz can be decreased when it is combined with Satralizumab.
Sildenafil Sildenafil The serum concentration of Sildenafil can be decreased when it is combined with Satralizumab.
Celecoxib Celecoxib The serum concentration of Celecoxib can be decreased when it is combined with Satralizumab.
Tolterodine Tolterodine The serum concentration of Tolterodine can be decreased when it is combined with Satralizumab.
Thalidomide Thalidomide The serum concentration of Thalidomide can be decreased when it is combined with Satralizumab.
Rabeprazole Rabeprazole The serum concentration of Rabeprazole can be decreased when it is combined with Satralizumab.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists